Trials / Sponsors / Peptomyc S.L.
Peptomyc S.L.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With P Metastatic Pancreatic Cancer | Phase 1 | 2023-08-31 |
| Terminated | Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours Advanced Solid Tumors, Pancreatic Cancer, CRC | Phase 1 / Phase 2 | 2021-04-28 |